Close Menu

codevelopment agreement

NEW YORK (GenomeWeb News) – EMD Millipore today announced a clinical research, licensing, and joint development deal with Japan's Sysmex aimed at creating a flow cytometry platform for blood disorders.

NEW YORK (GenomeWeb News) – Proteomics International recently announced an agreement with inVentiv Health Clinical aimed at the development of biosimilars.

NEW YORK (GenomeWeb News) – Horizon Discovery today said that it is collaborating with Desktop Genetics to develop a CRISPR design platform.

NEW YORK (GenomeWeb News) – Siemens Healthcare Diagnostics today said that it has signed a master collaboration agreement with Pfizer for the development of companion diagnostics for certain undisclosed therapeutic products in the drug giant's pipeline.

NEW YORK (GenomeWeb News) – Qiagen and Clovis Oncology announced after the close of the market on Monday a partnership to develop a companion diagnostic for a candidate oncology drug being developed by Clovis.

NEW YORK (GenomeWeb News) – BioTime subsidiary OncoCyte today announced that it will collaborate with the Wistar Institute on the development of a gene expression-based lung cancer test.

NEW YORK (GenomeWeb News) — Sysmex Inostics said today that it has inked a collaboration agreement with Bayer Healthcare to develop blood-based companion diagnostics for targeted anti-cancer therapies being developed by Bayer.

NEW YORK (GenomeWeb News) – Applied Proteomics today said that it will collaborate with the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) on the discovery and development of molecular diagnostic tests for colon and pancreatic cancer.

NEW YORK (GenomeWeb News) – MRC Technology today announced a collaboration with Renishaw Diagnostics to identify and develop clinical diagnostic tests for infectious diseases.

NEW YORK (GenomeWeb News) – Pacific Biosciences today announced an agreement with Roche Diagnostics to develop diagnostic products based on PacBio's SMRT technology.
Including upfront, milestone, and supply payments, the deal is potentially worth more than $75 million to PacBio.

Pages

A new study finds that three dimensional facial scans may be able to aid in diagnosing rare genetic diseases.

The Lancet and the New England Journal of Medicine have retracted two COVID-19 papers due to concerns about the data used in their analyses.

Lawmakers plan to introduce a bill that aims to prevent the theft of US-funded research, according to the Wall Street Journal.

In Science this week: analysis of ancient Caribbean islanders' genomes suggests at least three waves of migration into the region,  DNA barcoding of microbial spores, and more.